#
Omontys
  • Treatments
  • Anemia Associated with Chronic Renal Failure

Omontys

Generic name:peginesatidePEG-in-ES-a-tide ]
Drug class:Recombinant human erythropoietins

Medically reviewed by Drugs.com. Last updated on Jun 2, 2022.

What is Omontys?

Omontys is a man-made form of a protein that helps your body produce red blood cells. The amount of this protein in your body may be reduced when you have kidney failure or use certain medications. When fewer red blood cells are produced, you can develop a condition called anemia.

Omontys is used to treat anemia (a lack of red blood cells in the body) in people with chronic kidney disease who are on dialysis.

Omontys is not for treating anemia caused by other conditions. This medicine is not for use in people who are not on dialysis.

Omontys may also be used for purposes not listed in this medication guide.

Warnings

You should not use Omontys if you are allergic to peginesatide, or if you have untreated or uncontrolled high blood pressure.

Before using Omontys, tell your doctor if you have heart disease, congestive heart failure, high blood pressure, cancer, a seizure disorder, a blood cell or clotting disorder (such as sickle cell anemia or hemophilia), or a history of stroke, heart attack, or blood clot.

Your other medication doses may need to be changed after you start using Omontys. Tell your doctor about all medications you use.

To be sure Omontys is helping your condition, your iron and blood cells will need to be checked with frequent blood tests. Your blood pressure will also need to be checked often. Visit your doctor regularly.

Contact your doctor if you feel weak, lightheaded, or short of breath, or if your skin looks pale. These may be signs that your body has stopped responding to this medication.

Omontys can increase your risk of life-threatening heart or circulation problems, including heart attack or stroke. This risk will increase the longer you use Omontys. Seek emergency medical help if you have symptoms of heart or circulation problems, such as: chest pain, sudden numbness or weakness, severe headache, problems with vision or speech, sudden cough, coughing up blood, pain or warmth in your leg, cold or tingly feeling, feeling short of breath, rapid weight gain, or problems with your hemodialysis vein access.

Before using Omontys

You should not use Omontys if you are allergic to peginesatide, or if you have untreated or uncontrolled high blood pressure.

To make sure you can safely use Omontys, tell your doctor if you have any of these other conditions:

  • heart disease, congestive heart failure, or high blood pressure (hypertension);

  • a history of stroke, heart attack, or blood clot;

  • a blood cell or clotting disorder, such as sickle cell anemia or hemophilia;

  • cancer; or

  • epilepsy or another seizure disorder.

FDA pregnancy category C. It is not known whether Omontys will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication. It is not known whether peginesatide passes into breast milk or if it could harm a nursing baby. Do not use Omon...